MacroGenics reported $4.66M in Trade Creditors for its fiscal quarter ending in June of 2025.


Trade Creditors Change Date
AbbVie 2.94B 2.66B Dec/2024
Amgen USD 18.03B 15.63B Jun/2025
AstraZeneca 23.99B 1.44B Jun/2025
Biogen USD 408.4M 16.9M Jun/2025
Bristol-Myers Squibb USD 5.43B 1.42B Jun/2025
Daiichi Sankyo JPY 518.54B 61.41B Jun/2025
Eli Lilly USD 4.08B 633.7M Jun/2025
Genmab 5M 1.22M Mar/2025
Geron USD 8.23M 11.31M Jun/2025
Gilead Sciences USD 582M 155M Jun/2025
J&J USD 9.54B 766M Mar/2025
MacroGenics USD 4.66M 353K Jun/2025
Merck USD 4.04B 261M Jun/2025
Pfizer USD 5.17B 74M Jun/2025
Regeneron Pharmaceuticals USD 723.9M 18.4M Jun/2025
Roche Holding 4.35B 828M Dec/2024
Xencor USD 18.53M 2.34M Jun/2025